American College of Clinical Pharmacy
      Search      Cart
         

ACCP Efforts to Expand Pharmacy Specialty Recognition

ACCP has established this Web page to help members learn more about the specialist recognition process and to track the College’s progress toward achieving recognition of new clinical pharmacy specialties.

ACCP Memos to Board Certification Stakeholders
ACCP Report Excerpts on Expanding Specialist Certification
ACCP Member Surveys Regarding Specialist Certification

Board of Pharmacy Specialties (BPS) Process
for Considering a New Specialty
  1. An organization (with or without cosponsoring organizations) submits to BPS a brief proposal for consideration of a new pharmacy specialty following the guidelines issued by BPS, Preliminary Request for the Board of Pharmacy Specialties to Consider a New Specialty. These guidelines call for the preliminary proposal to include the name of the practice area of the proposed specialty; a description of the specialty practice area, the pharmacists engaged in it, and its overall impact on society; estimates of the number of pharmacists who might seek such certification; and documentation of organizational funding support to develop a full petition to BPS and to support implementation of the specialty before the receipt of candidate fees.
  2. BPS evaluates the preliminary request described in No. 1 above. If the request is judged to support the potential viability of the proposed specialty, BPS will undertake a formal role delineation study (RDS) to determine and analyze the tasks performed by practitioners in the specialty.
  3. BPS reviews the results of the RDS; if the Board finds that the RDS validates the area as a potential pharmacy specialty, a call will be issued for a formal petition requesting recognition of the specialty. Such petitions must include extensive documentation and justification of the potential specialty. This process typically requires several months to complete background research and petition preparation before submission to BPS.
  4. Once a petition supporting a new specialty is developed and submitted, BPS evaluates the petition, seeks profession-wide input on the petition and specialty, and then acts on the petition to either approve or deny the new specialty. During this process, the petition’s sponsoring organization(s) may be asked to amend or otherwise modify the petition.

 

Progress of Preliminary Requests for Consideration of a New Specialty Submitted to BPS.
Date Submitted Practice Area Request Approved by BPS? Role Delineation Study (RDS) Status
December 2012 Transplant Pharmacy Practice Pending TBA This is an updated resubmission of the request from February 2012. See April 24, 2013 BPS memo below.
February 2012 Cardiology Pharmacy Practice Yes Completed Approval announced by BPS February 14, 2017
February 2012 Infectious Diseases Pharmacy Practice Yes Completed Approval announced by BPS February 14, 2017
February 2012 Transplant Pharmacy Practice No TBA Request denied by BPS. Resubmitted in late 2012.
April 2011 Critical Care Pharmacy Practice Yes Completed
Approval announced by BPS April 15, 2013.
Joint petition submitted by ACCP, APhA and ASHP on November 15, 2012. See BPS call for comments.
April 2011 Pediatric Pharmacy Practice Yes Completed
Approval announced by BPS April 15, 2013.
Joint petition submitted by ACCP, APhA, ASHP, and PPAG on November 15, 2012. See BPS call for comments.

Other Documents of Interest